Tamar Kahn is a Health & Science Correspondent at Business Day. She has reported extensively on health, science, and education, with a focus on topics such as educational policy, mental health, and pharmaceuticals. Tamar's work has been recognized with multiple awards and she has been featured in prominent publications including Sowetan, Sunday Times, and HeraldLive.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
South Africa (National)
Not enough data
Tamar Kahn's coverage primarily focuses on health-related issues within South Africa, with a particular emphasis on government announcements and legal policy regulation. She appears to be interested in stories related to the National Health Insurance (NHI), healthcare funding, vaccine contracts, lobbying efforts, budget cuts, court cases in the context of public health issues such as mental health, HIV/AIDS prevention, and human rights.
Given this focus, individuals or organizations with expertise in public health policy and advocacy within South Africa may find success reaching out to Tamar. Specifically relevant would be those who can provide insight into government policies related to healthcare funding and NHI implementation. Additionally, sources who have data-driven insights or are involved in lobbying efforts around these topics may also appeal to her reporting interests.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Over 60% of debt deemed to be unrecoverable, MPs told
Minister cites need to stabilise student aid scheme before reforms get under way
Danish firm alleges health risks as iDexis defends right to supply weight-loss shots
Injections are illegal, Danish firm claims, while iDexis argues it is equivalent
SA’s medical scheme industry faces triple challenge, warns AlexForbes Health report
The Competition Commission has referred pharmaceutical manufacturer Adcock Ingram to the Competition Tribunal for prosecution for allegedly overcharging patients for its kidney dialysis products.
Competition watchdog pursues excessive-pricing case over kidney treatment products
Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir
Members complain about delays and a lack of response to authorisation requests
Pharmaceutical industry says state tenders threaten jobs and medicine supply security
